| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), ABSI's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 8.63M | $87.70M | - | |
| CFO | 484.9K | $4.93M | - | |
| Other | 421.4K | $965.1K | - | |
| Dir | 242.4K | - | - | |
| VP | 199.1K | $2.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 26, 2021 | Jonasson Zachariah | Director | Buy | 9,000 | $16.00 | $144,000.00 | New | -49.7% | -86.4% | |
| Jul 26, 2021 | Casdin Partners Master Fund, L.P.53 | Director | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +30.1% | -49.7% | -86.4% | |
| Jul 26, 2021 | Casdin Eli50 | Director | Buy | 1,562,500 | $16.00 | $25,000,000.00 | +30.1% | -49.7% | -86.4% | |
| Jul 26, 2021 | Bedrick Todd | VP, Ccpao | Buy | 1,000 | $16.00 | $16,000.00 | New | -49.7% | -86.4% |